Programmed death (PD)-1-Deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection

PLoS Pathogens

Volumn 7, Issue 7, 2011, Pages

  Chen, Yongwen ^a   Wu, Shengxi ^a,b   Guo, Guoning ^a   Fei, Lei ^a   Guo, Sheng ^a   Yang, Chengying ^a   Fu, Xiaolan ^a   Wu, Yuzhang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN; FIBRINOGEN LIKE PROTEIN 2; GAMMA INTERFERON; MEMBRANE PROTEIN; MESSENGER RNA; PROGRAMMED DEATH 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BLOCKING ANTIBODY; FGL2 PROTEIN, MOUSE; PDCD1 PROTEIN, MOUSE; PROGRAMMED DEATH 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GENETIC TRANSCRIPTION; HEPATITIS; HEPATITIS VIRUS; IN VIVO STUDY; INJURY SEVERITY; LIVER; LYMPH NODE; MACROPHAGE; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; THYMUS; TISSUE INJURY; UPREGULATION; VIROGENESIS; WILD TYPE; ANIMAL; ANIMAL HEPATITIS; DISEASE COURSE; DISEASE MODEL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; MOUSE MUTANT; MURINE HEPATITIS CORONAVIRUS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SURVIVAL RATE; TISSUE MICROARRAY; VIROLOGY;

MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS STRAIN 3; MUS;

ANIMALS; ANTIBODIES, BLOCKING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBRINOGEN; HEPATITIS, VIRAL, ANIMAL; HOST-PATHOGEN INTERACTIONS; INTERFERON-GAMMA; LIVER; LYMPHOID TISSUE; MICE; MICE, KNOCKOUT; MURINE HEPATITIS VIRUS; PROGRAMMED CELL DEATH 1 RECEPTOR; SIGNAL TRANSDUCTION; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960950244     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001347     Document Type: Article

References (36)

1. Rosen HR, Martin P, (2000) Viral hepatitis in the liver transplant recipient. Infect Dis Clin North Am 14: 761-784.
2. Pope M, Rotstein O, Cole E, Sinclair S, Parr R, et al. (1995) Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J Virol 69: 5252-60.
3. Levy GA, Leibowitz JL, Edgington TS, (1981) Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med 154: 1150-63.
4. Lucchiari MA, Martin JP, Modollel M, Pereira CA, (1991) Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon gamma synthesis and macrophage sensitivity to interferon gamma. J Gen Virol 72: 1317-1322.
5. Marsden PA, Ning Q, Fung LS, Luo X, Chen Y, et al. (2003) The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 112: 58-66.
6. Keir ME, Butte MJ, Freeman GJ, Sharpe AH, (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26: 677-704.
7. Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA, et al. (2004) PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett 574: 37-41.
8. Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL, (2004) SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 173: 945-54.
9. Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T, (2003) PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 198: 39-50.
10. Jun H, Seo SK, Jeong HY, Seo HM, Zhu G, et al. (2005) B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK). FEBS Lett 579: 6259-64.
11. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-87.
12. Velu V, Titanji K, Zhu B, Husain S, Pladevega A, et al. (2009) Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458: 206-10.
13. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, et al. (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12: 1198-202.
14. Penna A, Pilli M, Zerbini A, Orlandini A, Mezzadri S, et al. (2007) Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45: 588-601.
15. Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, et al. (2010) Programmed death-1-induced interleukin-10 production by monocytes impairs CD4(+) T cell activation during HIV infection. Nat Med 16: 452-9.
16. Das S, Suarez G, Beswick EJ, Sierra JC, Graham DY, et al. (2006) Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol 176: 3000-9.
17. Smith P, Walsh CM, Mangan NE, Fallon RE, Sayers JR, et al. (2004) Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand on macrophages. J Immunol 173: 1240-48.
18. Lázár-Molnár E, Gácser A, Freeman GJ, Almo SC, Nathenson SG, et al. (2008) The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc Natl Acad Sci U S A 105: 2658-63.
19. Terrazas LI, Montero D, Terrazas CA, Reyes JL, Rodriguez-Sosa M, (2005) Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Int J Parasitol 35: 1349-58.
20. Martinic MM, von Herrath MG, (2008) Novel strategies to eliminate persistent viral infections. Trends Immunol 29: 116-24.
21. Liu M, Mendicino M, Ning Q, Ghanekar A, He W, et al. (2006) Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol 176: 7028-38.
22. Hancock WW, Szaba FM, Berggren KN, Parent MA, Mullarky IK, et al. (2004) Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2. Proc Natl Acad Sci U S A 101: 3005-10.
23. Brown KE, Freeman GJ, Wherry EJ, Sharpe AH, (2010) Role of PD-1 in regulating acute infections. Curr Opinion Immunol 22: 397-401.
24. Huang X, Venet F, Wang YL, Lepape A, Yuan Z, et al. (2009) PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci USA 106: 6303-6308.
25. Fuse S, Tsai CY, Molloy MJ, Allie SR, Zhang W, et al. (2009) Recall responses by helpless memory CD8+ T cells are restricted by the upregulation of PD-1. J Immunol 182: 4244-4254.
26. Yao S, Wang S, Zhu Y, Luo L, Zhu G, et al. (2009) PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113: 5811-5818.
27. Dick GA, Niven JF, Gledhill AN, (1956) A virus related to that causing hepatitis in mice (MHV). Br J Exp Pathol 37: 90-98.
28. Ding JW, Ning Q, Liu MF, Lai A, Peltekian K, et al. (1998) Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. Adv Exp Med Biol 440: 609-18.
29. Ding JW, Ning Q, Liu MF, Lai A, Leibowitz J, et al. (1997) Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol 71: 9223-30.
30. Shalev I, Wong KM, Foerster K, Zhu Y, Chan C, et al. (2009) The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology 49: 387-97.
31. Marazzi S, Blum S, Hartmann R, Gundersen D, Schreyer M, et al. (1998) Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol 161: 138-47.
32. Shalev I, Liu H, Koscik C, Bartczak A, Javadi M, et al. (2008) Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J Immunol 180: 249-60.
33. Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, et al. (2009) PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119: 551-64.
34. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, et al. (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206: 3015-29.
35. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-8.
36. Chen Y, Zhang J, Li J, Zhao T, Zou L, et al. (2006) Triptolide inhibits B7-H1 expression on proinflammatory factor activated renal tubular epithelial cells by decreasing NF-kappaB transcription. Mol Immunol 43: 1088-98.